Boothbay Fund Management’s Urovant Sciences Ltd. UROV Stock Holding History

Boothbay Fund Management’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,500	Closed	-$363K	–	1990
2020 Q4	$363K	Buy	+22,500	New	+$279K	0.01%	874

Boothbay Fund Management's UROV Position: Q1 2021 in Review

Boothbay Fund Management sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 22,500 shares — an estimated $363K sold.

Boothbay Fund Management first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $363K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Boothbay Fund Management reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Boothbay Fund Management sold 22,500 Urovant Sciences Ltd. shares in Q1 2021, an estimated $363K.
Boothbay Fund Management first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Boothbay Fund Management's Urovant Sciences Ltd. position peaked at $363K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Boothbay Fund Management's 13F filing for Q1 2021, filed 17 May 2021.